Dossier
cancer-fighting power
Coverage of cancer-fighting power in the Nexus archive.
- A single protein may be holding back CAR T cancer therapy
A newly identified protein called NFIL3 is found to cause CAR T-cell therapy to lose effectiveness over time by inducing exhaustion in engineered immune cells. Disabling NFIL3 in animal models improved the cells' strength and tumor control.